Skip to content
10-Q

Quarterly Report

MARINUS PHARMACEUTICALS, INC.

0001558370-24-015315

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 5, 2024 55.19M sh
Shares Diluted Q3 2024 · Sep 30, 2024 57.23M sh
Shares Diluted Q3 2024 · Sep 30, 2024 57.05M sh
Shares Diluted Q3 2024 · Sep 30, 2023 53.92M sh
Shares Diluted Q3 2024 · Sep 30, 2023 52.76M sh
Capex Q3 2024 · Sep 30, 2024 $1.15M
Capex Q3 2024 · Sep 30, 2023 $85K
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$87.76M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$91.01M
Long Term Debt Q3 2024 · Sep 30, 2024 $56.25M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $42.18M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $120.57M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$66.74M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$47.35M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$16.43M
Stockholders Equity Q3 2024 · Dec 31, 2023 $16.77M
Stockholders Equity Q3 2024 · Sep 30, 2023 $54.54M
Stockholders Equity Q3 2024 · Jun 30, 2023 $57.34M
Stockholders Equity Q3 2024 · Mar 31, 2023 $85.09M
Stockholders Equity Q3 2024 · Dec 31, 2022 $116M
Current Liabilities Q3 2024 · Sep 30, 2024 $34.5M
Current Liabilities Q3 2024 · Dec 31, 2023 $40.62M
Total Liabilities Q3 2024 · Sep 30, 2024 $130.36M
Total Liabilities Q3 2024 · Dec 31, 2023 $154.14M
Current Assets Q3 2024 · Sep 30, 2024 $57.4M
Current Assets Q3 2024 · Dec 31, 2023 $165.25M
Total Assets Q3 2024 · Sep 30, 2024 $63.62M
Total Assets Q3 2024 · Dec 31, 2023 $170.91M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.42
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.73
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.61
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.89
Eps Basic Q3 2024 · Sep 30, 2024 −$0.42
Eps Basic Q3 2024 · Sep 30, 2024 −$1.73
Eps Basic Q3 2024 · Sep 30, 2023 −$0.61
Eps Basic Q3 2024 · Sep 30, 2023 −$1.89
Sga Expense Q3 2024 · Sep 30, 2024 $12.57M
Sga Expense Q3 2024 · Sep 30, 2024 $47.91M
Sga Expense Q3 2024 · Sep 30, 2023 $14.87M
Sga Expense Q3 2024 · Sep 30, 2023 $45.79M
Rd Expense Q3 2024 · Sep 30, 2024 $16.33M
Rd Expense Q3 2024 · Sep 30, 2024 $61.35M
Rd Expense Q3 2024 · Sep 30, 2023 $23.66M
Rd Expense Q3 2024 · Sep 30, 2023 $73.01M
Net Income Q3 2024 · Sep 30, 2024 −$24.23M
Net Income Q3 2024 · Sep 30, 2024 −$98.7M
Net Income Q3 2024 · Jun 30, 2024 −$35.83M
Net Income Q3 2024 · Mar 31, 2024 −$38.67M
Net Income Q3 2024 · Sep 30, 2023 −$32.97M
Net Income Q3 2024 · Jun 30, 2023 −$31.93M
Net Income Q3 2024 · Mar 31, 2023 −$34.73M
Operating Income Q3 2024 · Sep 30, 2024 −$21.08M
Operating Income Q3 2024 · Sep 30, 2024 −$89.14M
Operating Income Q3 2024 · Sep 30, 2023 −$31.65M
Operating Income Q3 2024 · Sep 30, 2023 −$96.05M